Regeneron Acquires 23andMe Data for $256M
Regeneron Acquires 23andMe Data for $256M Regeneron Pharmaceuticals has announced its plan to acquire 23andMe for $256 million, following the latter’s Chapter 11 bankruptcy filing in March 2025. This acquisition...